Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome

Critical Care Medicine

Volumn 24, Issue 7, 1996, Pages 1196-1202

  Jansen, Monique J J M ^a   Hendriks, Thijs ^a   Vogels, Maria T E ^a   Van Der Meer, Jos W M ^a   Goris, R Jan A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

animal model; cytokines; interleukin 1; interleukin 6; mouse; multiple organ dysfunction syndrome; peritoneal macrophage; tumor necrosis factor; zymosan

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MULTIPLE ORGAN FAILURE; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 0029889088     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199607000-00022     Document Type: Article

References (29)

1. Members of the American College of Chest physicians/Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
2. Faist EA, Baue E, Dittmer H, et al: Multiple organ failure in poly-trauma patients. J Trauma 1983; 23:775-787
3. Marshall WG, Dimick AR: Natural history of major burns with multiple subsystem failure. J Trauma 1983; 23: 102-105
4. Saffle JR, Sullivan JJ, Tuohig GM, et al: Multiple organ failure in patients with thermal injury. Crit Care Med 1993; 21: 1673-1683
5. Aikowa N, Shinozawa Y, Ishibiki K: Clinical analysis of Multiple Organ Failure in burned patients. Burns 1987; 13: 103-109
6. Allardyce DB: Incidence of necrotizing pancreatitis and factors related to mortality. Am J Surg 1987; 154:295-299
7. Baue AE, Guthrie D: Multiple system failure and circulatory support. Jpn J Surg 1983; 13:69-85
8. Deitch EA: Multiple organ failure. Ann Surg 1992; 216:117-134
9. Goris RJA, Boekholtz WKF, van Bebber IPT, et al: Multiple organ failure and sepsis without bacteria. Arch Surg 1986; 121:897-901
10. Auger MJ: Mononuclear phagocytes. BMJ 1989; 298:546-548
11. Johnston Jr RB: Monocytes and macrophages. N Engl J Med 1988; 318: 747-752
12. Nathan CF: Secretory products of macrophages. J Clin Invest 1987; 79:319-326
13. Le J, Vilcek J: Biology of disease. Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234-248
14. Nerad JL, Griffiths JK, van der Meer JWM, et al: Interleukin-1β (IL-1β), IL-1 receptor antagonist, and TNF-α production in whole blood. J Leuk Biol 1992; 52:687-691
15. Calandra T, Gerain J, Baumgartner JD, et al: High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991; 91:23-29
16. Goris RJA: Mediators of multiple organ failure. Intensive Care Med 1990; 16: 192-196
17. Goris RJA, te Boekhorst TPA, Nuytinck JKS, et al: Multiple Organ Failure. Generalized autodestructive inflammation? Arch Surg 1985; 120:1109-1115
18. Roumen RMH, Hendriks T, van der Ven-Jongekrijg J, et al: Cytokine patterns in patients after major vascular surgery, haemorrhagic shock and severe blunt trauma: Relation with subsequent ARDS and MOF. Ann Surg 1993; 218: 769-776
19. Nuytinck JKS, Offermans XJM, Kubat K, et al: Whole-body inflammation in trauma patients. Arch Surg 1988; 123: 1519-1524
20. Tracey KJ, Cerami A: Tumor necrosis factor: An updated review of its biology. Crit Care Med 1993; 21:3415-8422
21. Beutler B, Grau GE: Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993; 21: S423-S435
22. Steinberg S, Flynn W, Kelley K, et al: Development of a bacteria-independent model of the multiple organ failure syndrome. Arch Surg 1989; 124:1390-1395
23. Deitch EA, Abbie C, Kemper BS, et al: A study of the relationships among survival, gut-origin sepsis, and bacterial translocation in a model of systemic inflammation. J Trauma 1992; 32: 141-147
24. Bebber van IPT, Lieners CFJ, Koldewijn EL, et al: Superoxide dismutase and catalase in an experimental model of multiple organ failure. J Surg Res 1992; 52:265-270
25. Ayala A, Kisala JM, Felt JA, et al: Does endotoxin tolerance prevent the release of inflammatory cytokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis. Arch Surg 1992; 127: 191-197
26. Ayala A, Perrin MM, Kisala JM, et al: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukin-1, and -6 and tumor necrosis factor). Circ Shock 1992; 36:191-199
27. Deuren van M, van der Ven-Jongekrijg J, Demacker PNM, et al: Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 1994; 169:157-161
28. Stein M, Gordon S: Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: Role of cell stimulation and specific phagocytic plasma membrane receptors. Eur J Immunol 1991; 21:431-137
29. Wollenberg GK, DeForge LE, Bolgos G, et al: Differential expression of tumor necrosis factor and interleukin 6 by peritoneal macrophages in vivo and in culture. J Pathol 1993; 143:1121-1130